Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Imperiale

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
The American Journal of Gastroenterology|September 7, 2010
Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?Thomas F Imperiale
Archives of Internal Medicine|August 10, 2011
Screening for colorectal cancer in the elderly population: how much is enough?Thomas F Imperiale
Endoscopy|December 3, 2015
Risk and outcomes of metachronous gastric cancer following endoscopic resection of early gastric cancer: some answers, more questionsThomas F Imperiale, Melissa Martinez
Journal of Clinical Gastroenterology|February 3, 2012
Second-look endoscopy for bleeding peptic ulcer disease: a decision-effectiveness and cost-effectiveness analysisThomas F Imperiale, Nan Kong
Gastroenterology|March 1, 2011
Interval fecal immunochemical testing in colonoscopic surveillance programDavid Lieberman, Thomas F Imperiale
Gastroenterology|March 2, 2016
ReplyThomas F Imperiale, David F Ransohoff
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
Cost-effectiveness of Future Biomarkers for Colorectal Cancer Screening: Quantified Futility or Call for Innovation?Thomas F Imperiale, Charles J Kahi
Gastrointestinal Endoscopy Clinics of North America|May 23, 2020
Risk Stratification Strategies for Colorectal Cancer Screening: From Logistic Regression to Artificial IntelligenceThomas F Imperiale, Patrick O Monahan
The New England Journal of Medicine|January 4, 2008
CT colonography versus colonoscopy for the detection of advanced neoplasiaDouglas K Rex, Thomas F Imperiale
Neurogastroenterology and Motility|December 18, 2018
Refers to: Paul Enck. Not more, but less studies are warranted-If you take your meta-analysis seriouslyAndrea S Shin, Thomas F Imperiale
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
The American Journal of Gastroenterology|September 7, 2010
Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?Thomas F Imperiale
Archives of Internal Medicine|August 10, 2011
Screening for colorectal cancer in the elderly population: how much is enough?Thomas F Imperiale
Endoscopy|December 3, 2015
Risk and outcomes of metachronous gastric cancer following endoscopic resection of early gastric cancer: some answers, more questionsThomas F Imperiale, Melissa Martinez
Journal of Clinical Gastroenterology|February 3, 2012
Second-look endoscopy for bleeding peptic ulcer disease: a decision-effectiveness and cost-effectiveness analysisThomas F Imperiale, Nan Kong
Gastroenterology|March 1, 2011
Interval fecal immunochemical testing in colonoscopic surveillance programDavid Lieberman, Thomas F Imperiale
Gastroenterology|March 2, 2016
ReplyThomas F Imperiale, David F Ransohoff
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
Cost-effectiveness of Future Biomarkers for Colorectal Cancer Screening: Quantified Futility or Call for Innovation?Thomas F Imperiale, Charles J Kahi
Gastrointestinal Endoscopy Clinics of North America|May 23, 2020
Risk Stratification Strategies for Colorectal Cancer Screening: From Logistic Regression to Artificial IntelligenceThomas F Imperiale, Patrick O Monahan
The New England Journal of Medicine|January 4, 2008
CT colonography versus colonoscopy for the detection of advanced neoplasiaDouglas K Rex, Thomas F Imperiale
Neurogastroenterology and Motility|December 18, 2018
Refers to: Paul Enck. Not more, but less studies are warranted-If you take your meta-analysis seriouslyAndrea S Shin, Thomas F Imperiale
Pageof 18